PATENT CLAIM ANALYSIS

Application Number: 15904935
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "252160"]

Abstract:
The present disclosure provides pharmaceutical compositions including a CDK inhibitor and an HSP90 inhibitor, as well as methods of treating cancer or a tumor in a subject by administering a CDK inhibitor and an HSP90 inhibitor to the subject.

Claim (Index 7):
A method of treating cancer or a tumor in a subject in need thereof, comprising:\n administering a CDK inhibitor to the subject; and administering an HSP90 inhibitor to the subject; provided that both RO-3306 and geldanamycin are not administered to the subject.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.41379
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14131183', '15115606', '15026413', '15103187', '14229221']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466522413224184
- 35 USC 102 Novelty (BERT): 0.5028576535019226
- Combined Prediction Score: 0.7222727825403688
- Mean Citation Score: 245.182056
- Max Citation Score: 255.38828
- Similarity Product: 181.1522453403712

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test